Amendola D, De Salvo M, Marchese R, Verga Falzacappa C, Stigliano A, Carico E, Brunetti E, Moscarini M, Bucci B
Centro Ricerca S. Pietro, Fatebenefratelli Hospital, Rome, Italy.
Cell Prolif. 2009 Feb;42(1):94-109. doi: 10.1111/j.1365-2184.2008.00576.x.
We investigated the antiproliferative effect of Myc down-regulation via cell proliferation inhibition, cell cycle perturbation and apoptosis in two human astrocytoma models (T98G and ADF) steadily expressing an inducible c-myc Anti-sense RNA.
Cell growth experiments were performed using the trypan blue dye exclusion test and cell cycle analysis was evaluated by flow cytometry. Cell cycle molecules were detected by Western blot analysis, co-immunoprecipitation and reverse transcription-polymerase chain reaction assays.
We showed that Myc down-regulation in astrocytoma cells led to G1 accumulation and an inhibition of cell proliferation characterized by S phase delay. Co-immunoprecipitation experiments detected formation of inactive cyclin D1/cdk4 complexes as evaluated by presence of an active unphosphorylated form of retinoblastoma protein, the best characterized target substrate for cyclin D1/cdk4 complex, in ADF pINDc-myc anti-sense 7 cells. We also found that either p57Kip2 "apice" or p27Kip1 "apice" inhibitors bound to cyclin D1/cdk4 complex, thus, suggesting that they cooperated to inhibit the activity of cyclin D1/cdk4. Moreover, c-Myc down-regulation led to activation of the apoptotic mitochondrial pathway, characterized by release of cytochrome c and Smac/Diablo proteins and by reduction of c-IAP levels through activation of proteasome-mediated protein degradation system.
Our results suggest that c-Myc could be considered as a good target for the study of new approaches in anticancer astrocytoma treatment.
我们通过细胞增殖抑制、细胞周期扰动和凋亡,在两种稳定表达可诱导型c-myc反义RNA的人星形细胞瘤模型(T98G和ADF)中研究了Myc下调的抗增殖作用。
使用台盼蓝染料排除试验进行细胞生长实验,并通过流式细胞术评估细胞周期分析。通过蛋白质免疫印迹分析、免疫共沉淀和逆转录-聚合酶链反应测定法检测细胞周期分子。
我们发现星形细胞瘤细胞中Myc下调导致G1期积累,并以S期延迟为特征抑制细胞增殖。免疫共沉淀实验检测到在ADF pINDc-myc反义7细胞中形成了无活性周期蛋白D1/细胞周期蛋白依赖性激酶4(cdk4)复合物,这是通过视网膜母细胞瘤蛋白(周期蛋白D1/cdk4复合物最具特征的靶底物)的活性未磷酸化形式的存在来评估的。我们还发现,p57Kip2“顶点”或p27Kip1“顶点”抑制剂与周期蛋白D1/cdk4复合物结合,因此,表明它们协同抑制周期蛋白D1/cdk4的活性。此外,c-Myc下调导致凋亡线粒体途径的激活,其特征是细胞色素c和Smac/Diablo蛋白的释放,以及通过蛋白酶体介导的蛋白质降解系统的激活导致c-IAP水平降低。
我们的结果表明,c-Myc可被视为研究星形细胞瘤抗癌治疗新方法的良好靶点。